These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34117577)

  • 1. Prognostic Impact of Different Gleason Patterns on Biopsy Within Grade Group 4 Prostate Cancer.
    Mori K; Sharma V; Comperat EM; Sato S; Laukhtina E; Schuettfort VM; Pradere B; Sari Motlagh R; Mostafaei H; Quhal F; Kardoust Parizi M; Abufaraj M; Karakiewicz PI; Egawa S; Tilki D; Boorjian SA; Shariat SF
    Ann Surg Oncol; 2021 Dec; 28(13):9179-9187. PubMed ID: 34117577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential prognostic impact of different Gleason patterns in grade group 4 in radical prostatectomy specimens.
    Mori K; Sharma V; Comperat EM; Sato S; Laukhtina E; Schuettfort VM; Pradere B; Parizi MK; Karakiewicz PI; Egawa S; Tilki D; Boorjian SA; Shariat SF
    Eur J Surg Oncol; 2021 May; 47(5):1172-1178. PubMed ID: 33371950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic impact of downgrading and upgrading from biopsy to radical prostatectomy among men with Gleason score 7 prostate cancer.
    Jang WS; Koh DH; Kim J; Lee JS; Chung DY; Ham WS; Rha KH; Choi YD
    Prostate; 2019 Dec; 79(16):1805-1810. PubMed ID: 31483062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Prostate Cancer Grading System Predicts Long-term Survival Following Surgery for Gleason Score 8-10 Prostate Cancer.
    Ham WS; Chalfin HJ; Feng Z; Trock BJ; Epstein JI; Cheung C; Humphreys E; Partin AW; Han M
    Eur Urol; 2017 Jun; 71(6):907-912. PubMed ID: 27876305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tertiary Gleason pattern in radical prostatectomy specimens is associated with worse outcomes than the next higher Gleason score group in localized prostate cancer.
    Özsoy M; D'Andrea D; Moschini M; Foerster B; Abufaraj M; Mathieu R; Briganti A; Karakiewicz PI; Roupret M; Seitz C; Czech AK; Susani M; Shariat SF
    Urol Oncol; 2018 Apr; 36(4):158.e1-158.e6. PubMed ID: 29288003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gleason grade grouping of prostate cancer is of prognostic value in Asian men.
    Yeong J; Sultana R; Teo J; Huang HH; Yuen J; Tan PH; Khor LY
    J Clin Pathol; 2017 Sep; 70(9):745-753. PubMed ID: 28289065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and pathologic predictors of Gleason sum upgrading in patients after radical prostatectomy: results from a single institution series.
    Tilki D; Schlenker B; John M; Buchner A; Stanislaus P; Gratzke C; Karl A; Tan GY; Ergün S; Tewari AK; Stief CG; Seitz M; Reich O
    Urol Oncol; 2011; 29(5):508-14. PubMed ID: 19837614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of prostate health index to predict Gleason score upgrading and high-risk prostate cancer in radical prostatectomy specimens.
    Kim H; Jung G; Kim JH; Byun SS; Hong SK
    Sci Rep; 2021 Aug; 11(1):17447. PubMed ID: 34465825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Gleason score on biochemical recurrence in patients with pT3aN0/Nx prostate cancer with positive surgical margins: a multicenter study from the Prostate Cancer Research Committee.
    Song W; Lee DH; Jeon HG; Jeong BC; Seo SI; Lee HM; Choi HY; Kim JW; Lee S; Byun SS; Jeong CW; Kwak C; Cho JS; Ahn H; Jeon SS
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2393-2400. PubMed ID: 28823006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer upgrading or downgrading of biopsy Gleason scores at radical prostatectomy: prediction of "regression to the mean" using routine clinical features with correlating biochemical relapse rates.
    Altok M; Troncoso P; Achim MF; Matin SF; Gonzalez GN; Davis JW
    Asian J Androl; 2019; 21(6):598-604. PubMed ID: 31115364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinically predictive factors of Gleason score upgrading in patients after radical prostatectomy].
    Zuo Q; Zhang F; Huang Y; Ma LL; Lu M; Lu J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Aug; 48(4):603-606. PubMed ID: 29263497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of high grade tertiary Gleason pattern upgrades the Gleason sum score and is inversely associated with biochemical recurrence-free survival.
    Turker P; Bas E; Bozkurt S; Günlüsoy B; Sezgin A; Postacı H; Turkeri L
    Urol Oncol; 2013 Jan; 31(1):93-8. PubMed ID: 21316989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Significance of Primary Biopsy Gleason 5 in Patients with Grade Group 5 Prostate Cancer.
    Tilki D; Würnschimmel C; Preisser F; Graefen M; Huland H; Mandel P; Tennstedt P
    Eur Urol Focus; 2020 Mar; 6(2):255-258. PubMed ID: 32033909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary Gleason grade 4 at the positive margin is associated with metastasis and death among patients with Gleason 7 prostate cancer undergoing radical prostatectomy.
    Viers BR; Sukov WR; Gettman MT; Rangel LJ; Bergstralh EJ; Frank I; Tollefson MK; Thompson RH; Boorjian SA; Karnes RJ
    Eur Urol; 2014 Dec; 66(6):1116-24. PubMed ID: 25052213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upgrading and downgrading of prostate cancer from biopsy to radical prostatectomy: incidence and predictive factors using the modified Gleason grading system and factoring in tertiary grades.
    Epstein JI; Feng Z; Trock BJ; Pierorazio PM
    Eur Urol; 2012 May; 61(5):1019-24. PubMed ID: 22336380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term cancer control outcomes in patients with clinically high-risk prostate cancer treated with robot-assisted radical prostatectomy: results from a multi-institutional study of 1100 patients.
    Abdollah F; Sood A; Sammon JD; Hsu L; Beyer B; Moschini M; Gandaglia G; Rogers CG; Haese A; Montorsi F; Graefen M; Briganti A; Menon M
    Eur Urol; 2015 Sep; 68(3):497-505. PubMed ID: 26119559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The New Prostate Cancer Grading System Does Not Improve Prediction of Clinical Recurrence After Radical Prostatectomy: Results of a Large, Two-Center Validation Study.
    Dell'Oglio P; Karnes RJ; Gandaglia G; Fossati N; Stabile A; Moschini M; Cucchiara V; Zaffuto E; Karakiewicz PI; Suardi N; Montorsi F; Briganti A
    Prostate; 2017 Feb; 77(3):263-273. PubMed ID: 27753114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of pathologically localized high-grade prostate cancer treated with radical prostatectomy.
    Heo JE; Park JS; Lee JS; Kim J; Jang WS; Rha KH; Choi YD; Hong SJ; Ham WS
    Medicine (Baltimore); 2019 Oct; 98(42):e17627. PubMed ID: 31626145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the Time Interval from Biopsy to Radical Prostatectomy Affect the Postoperative Oncologic Outcomes in Korean Men?
    Kim SJ; Ryu JH; Yang SO; Lee JK; Jung TY; Kim YB
    J Korean Med Sci; 2019 Sep; 34(37):e234. PubMed ID: 31559708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical impact of prostate biopsy undergrading in an academic and community setting.
    Mortezavi A; Keller EX; Poyet C; Hermanns T; Saba K; Randazzo M; Fankhauser CD; Wild PJ; Moch H; Sulser T; Eberli D
    World J Urol; 2016 Oct; 34(10):1481-90. PubMed ID: 26931560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.